GPNMB confers risk for Parkinson's disease through interaction with α-synuclein by Diaz-Ortiz, Maria E, Seo, Yunji, Posavi, Marijan, Carceles Cordon, Marc, Clark, Elisia, Jain, Nimansha, Charan, Rakshita, Gallagher, Michael D, Unger, Travis L, Amari, Noor, Skrinak, R Tyler, Davila-Rivera, Roseanne, Brody, Eliza M, Han, Noah, Zack, Rebecca, Van Deerlin, Vivianna M, Tropea, Thomas F, Luk, Kelvin C, Lee, Edward B, Weintraub, Daniel, Chen-Plotkin, Alice S

Get full text

Increased expression of the frontotemporal dementia risk factor TMEM106B causes C9orf72-dependent alterations in lysosomes by Busch, Johanna I, Unger, Travis L, Jain, Nimansha, Tyler Skrinak, R, Charan, Rakshita A, Chen-Plotkin, Alice S

Get full text

Plasma MIA, CRP, and Albumin Predict Cognitive Decline in Parkinson's Disease by Shen, Junchao, Amari, Noor, Zack, Rebecca, Skrinak, R. Tyler, Unger, Travis L., Posavi, Marijan, Tropea, Thomas F., Xie, Sharon X., Van Deerlin, Vivianna M., Dewey, Richard B., Weintraub, Daniel, Trojanowski, John Q., Chen‐Plotkin, Alice S.

Get full text

Characterization of Parkinson's disease using blood-based biomarkers: A multicohort proteomic analysis by Posavi, Marijan, Diaz-Ortiz, Maria, Liu, Benjamine, Swanson, Christine R, Skrinak, R Tyler, Hernandez-Con, Pilar, Amado, Defne A, Fullard, Michelle, Rick, Jacqueline, Siderowf, Andrew, Weintraub, Daniel, McCluskey, Leo, Trojanowski, John Q, Dewey, Jr, Richard B, Huang, Xuemei, Chen-Plotkin, Alice S

Get full text

GPNMB Biomarker Levels in GBA1 Carriers with Lewy Body Disorders by Brody, Eliza M., Seo, Yunji, Suh, EunRan, Amari, Noor, Hartstone, Whitney G., Skrinak, R. Tyler, Zhang, Hanwen, Diaz‐Ortiz, Maria E., Weintraub, Daniel, Tropea, Thomas F., Van Deerlin, Vivianna M., Chen‐Plotkin, Alice S.

Get full text